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Summary 
The intracellular  parasite Listeria  monocytogenes is able to induce  its internalization  by cultured 
mammalian cells that are not normally phagocytic.  This process requires the expression of the 
chromosomal locus  inlAB.  We studied  the  virulence  of an  inlAB mutant  and  of its parent in 
rnurine listeriosis. Irrespective of the route of inoculation,  the inlAB mutant was severely atten- 
uated for growth in the liver.  The livers of mice inoculated  with  the  inlAB mutant  displayed 
much smaller infectious foci than the parent as  early as 24 h  after infection.  Electron micros- 
copy showed that these foci consisted of a few inflammatory cells, with few bacteria; bacteria 
were  rarely found  within  hepatocytes.  In contrast,  foci in livers  of mice inoculated  with  the 
parent consisted of islets of heavily infected hepatocytes that were infiltrated by numerous neu- 
trophils;  bacteria seemed intact within  hepatocytes  and damaged within  neutrophils.  A  direct 
role of inlAB for the  entry of L.  monocytogenes into hepatocytes was confirmed in a cell infec- 
tion  system using the  murine  embryonic  hepatocyte  cell line  TIB73.  The  inlAB mutant  was 
~20-fold less invasive than its parent and recovered a full invasive phenotype when inlAB was 
provided in trans. The "invasion locus" inlAB contributes  to protect L.  monocytogenes from the 
host's innate defense mechanisms by promoting its entry into hepatocytes. 
V 
arious bacterial pathogens are able to trigger their up- 
take  by  cultured  mammalian  cells  that  are  not  nor- 
mally phagocytic,  such  as  epithelial  cells or fibroblasts  (1). 
Much work in recent years has addressed the bacterial fac- 
tors involved in the process of entry. Loci required  for in- 
vasion  of nonprofessional  phagocytic  cells  have  thus  been 
identified  in  the  genomes  of Gram-negative  and  Gram- 
positive bacteria, including  Yersinia (2, 3), Salmonella  (4, 5), 
Shigella  (6),  and Listeria  (7).  It is a seductive idea that these 
"invasion  loci"  may contribute  to virulence  by giving the 
bacteria access to an intracellular  niche protected from the 
host's phagocytes (8). However, to date, there is no experi- 
mental evidence for this hypothesis. 
Listeria  monocytogenes is a particularly attractive model for 
investigating the role of invasion loci in vivo. This ubiqui- 
tous Gram-positive bacterium can infect both macrophages 
(9)  and  nonprofessional  phagocytes,  including  epithelial 
cells, fibroblastic cells, and hepatocytes (10-14).  It is a well- 
adapted intracellular pathogen that can grow within the cy- 
toplasm of its host  cell  (11,  15)  and takes advantage of the 
host  cell  machinery  to pass  directly  into  the  cytoplasm  of 
neighboring host cells (16,  17). Murine  listeriosis is a well- 
documented  model of infection  and has been widely used 
for studying cellular immunity. 
By analysis of noninvasive transposon insertion  mutants, 
we  have  recently  identified  a  chromosomal  locus  that  is 
absolutely  required  for the  entry  of L.  monocytogenes  into 
cultured  epithelial  cells  (7).  This locus is an operon  and is 
controlled  by the activator PrfA (18),  as are the virulence- 
related  genes of the  hly region  (19,  20).  It is composed of 
two  genes,  inlA  and  inlB.  The  inlA  gene  is necessary and 
sufficient  to render the  normally noninvasive  species Liste- 
ria  innocua invasive for cultured  epithelial  cells.  It encodes 
an 800-amino acid protein, internalin,  which is structurally 
analogous  to  certain  surface proteins  in  Gram-positive or- 
ganisms  (7,  21).  The  inlB gene  is very similar to  inlA  and 
encodes a 630-amino acid protein. 
After entering the host through the gastrointestinal tract, 
L.  monocytogenes spreads via the lymph and blood to distant 
tissues.  In murine  infection,  it accumulates  predominantly 
in  the  liver,  where  it  replicates  until  the  host  mobilizes  a 
protective  cellular immune response  (9,  22,  23).  Until  re- 
cently,  it  was  generally  believed  that  the  growth  of L. 
monocytogenes  in  the  liver  was  due  to  its  ability  to  grow 
within  the  resident  macrophages,  the  Kiipffer  cells  (9). 
However,  several  recent  works  have  clearly  shown  that 
L. monocytogenes  replicates  in  hepatocytes  rather  than  in 
Kiipffer cells  (13,  24-26).  In  mice  infected  intravenously 
with a sublethal dose, there is an ~200-fold  increase in the 
number  of hepatocyte-associated  Listeria  during  the  first 
3 d,  and  a  <twofold  increase  in  the  number  of Kiipffer 
cell-associated  Listeria  (26).  Hepatocyte  invasion  is  now 
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alyzed in in vitro cellular assay systems (14). 
We studied the  role  of intAB  in routine listeriosis and 
provide evidence that this locus allows L.  monocytogenes  to 
circumvent the  host's innate defense mechanisms by pro- 
moting its entry into hepatocytes. 
Materials and Methods 
Bacterial Strains and Growth Conditions.  L. monocytogenes strains 
EGD-SmR and BUG8 were used throughout the study.  EGD- 
SmlL  is a streptomycin-resistant derivative of strain  EGD  (27). 
BUG8 is a transposon Tni545 mutant from EGD-SmP,, which is 
,'-,50-fold less invasive than its parent for cultured epithelial cells 
(7). The transposon insertion in BUG8, 417 bp upstream of the 
start  codon of inlA (21), prevents the transcription of inlA  and 
inlB  (7). The  BUG8-derivative strains JLG101,  JLG102,  and 
JLG103 were obtained in this study. JLG102 and JLG103 harbor 
the pAT28 derivatives  pGM4 and pGM2, respectively; JLG101 
harbors the vector pAT28. Plasmids pGM2 and pGM4 have been 
described  elsewhere;  they carry inlAB and inlA, respectively  (7). 
Plasmid pAT28 and derivatives  were introduced into Escherichia 
coil strain HB101  (pRK212.1) by transformation and transferred 
from  E.  coli to  L.  monocytogenes BUG8  by  conjugation  (7). 
Transconjugants were  selected  on  tryptic  soy  agar  containing 
spectinomycin  (60  mg/liter)  and  nalidixic  acid  (50  rag/liter) 
(Sigma  Chemical  Co.,  St.  Louis,  MO). JLG101, JLG102,  and 
JLG103 were used for  in vitro but not for in vivo experiments, 
owing to the instability  of the vector pAT28 and derivatives  in 
these strains, g  innocua BUG263, BUG261, and BUG531 derive 
from  the  strain  CLIP11254  and  harbor  the  plasmids  pAT28, 
pGM2, and pGM4, respectively (7, 18). Listeria strains were grown 
in tryptic  soy  broth  (Diagnostics  Pasteur,  Marnes-la-Coquette, 
France)  at 37~  without shaking.  Spectinomycin (60  rag/liter) 
was added to cultures of strains harboring plasmid pAT28 and de- 
rivatives. 
Analysis of Virulence in Mice.  Specific  pathogen-free female Swiss 
mice (Charles Rivers, Saint-Aubin-l~s-Elbeuf,  France) were used 
when they were 6-8 wk old.  The challenge  inoculum was pre- 
pared from 18-h cultures in tryptic soy broth, containing antibi- 
otics as appropriate. Bacteria were pelleted by centrifugation, washed 
once, and diluted appropriately  in 0.15 M  NaC1. Mice were in- 
fected by direct intragastric inoculation with 109 bacteria (in 0.25 
ml) by means of a feeding needle for oral challenge, and by intra- 
venous injection of either 5 ￿  10  s or 3 ￿  10  ~ bacteria  (in 0.5 ml) 
for  intravenous challenge.  Bacterial  growth  in liver and spleen 
was determined by killing groups of five mice at various intervals 
after infection. Mice were killed by cervical dislocation,  in accor- 
dance  with the policies  of the animal welfare  committee of the 
Facult6 Necker-Enfants Malades. The liver and spleen were asep- 
tically removed and ground. Samples (0.1 ml) of serial dilutions of 
whole-organ homogenates were surface plated on tryptic soy agar 
(Diagnostics  Pasteur).  Bacterial  counts in BUG8-infected mice 
were determined in parallel on tryptic soy agar containing or not 
containing kanamycin (25  mg/liter)  to  assess the  presence  of 
Tn1545 in bacteria. Colonies were counted after 24 h of incuba- 
tion at  37~  and the  results were  expressed  as the mean log10 
bacteria per organ. The minimum detection limit was 2 logm bac- 
teria per organ. The intravenous LDs0 was estimated by the probit 
method. Groups of eight mice were challenged intravenously  with 
various doses of bacteria, and mortality was observed for 3 wk. 
Histology.  Mice were  challenged  intravenously with a dose 
of 108 bacteria  (in 0.5 ml) and killed by cervical dislocation at in- 
tervals of up to  1 wk.  Small pieces  of liver were removed and 
processed  for  Gram staining, immunolabeling, or  electron mi- 
croscopy. Samples to be Gram stained were fixed in 10% formalin 
and embedded in paraffin; 2-3-1xm sections were cut and stained 
using the  Gram-Weigert procedure.  Samples to  be imnmnola- 
beled  were  embedded  in  OCT  compound  (Miles  Scientific, 
Naperville,  IL)  and  frozen  in liquid-cooled isopentane (Sigma 
Chemical  Co.).  Cryostat  sections  5-7-txm  thick  were  cut, 
mounted onto glass slides, and fixed  in acetone. Sections  were 
first incubated with a rabbit anti-L, monocytogenes serum (1:100 
dilution) for 1 h, and then with peroxidase-conjugated goat anti- 
rabbit IgG  (1:100  dilution) (Sigma Chemical Co.).  3,3'-diasni- 
nobenzidine (Sigma Chemical Co.) was used as the chromogenic 
substrate to reveal bound peroxidase.  Samples to be processed for 
electron  microscopy  were  fixed  in  2%  glutaraldehyde  (Sigma 
Chemical Co.)  in 0.1  M  phosphate  buffer,  pH  7.4,  for  2  h  at 
room  temperature, postfixed  in 2%  aqueous osmium tetroxide 
(Merck,  Darmstadt,  Germany) for 1 h, dehydrated  in graded eth- 
anol  solutions,  and  embedded  in  Epon  812  (TAA-Jamming, 
France).  Senfithin sections  were cut and stained  with  1% tolui- 
dine blue for light microscopy.  Ultrathin sections of the appropri- 
ate blocks were cut, stained with uranyl acetate and lead citrate, 
and examined with an electron microscope  (model CX200; Jeol, 
Croissy-sur-Seine, France). 
Culture of the Cell Line TIB73.  The murine embryomc hepa- 
tocyte  cell line TIB73 was purchased  from the American Type 
Culture Collection (Rockville, MD). It was cultured in DMEM 
(Gibco Laboratories,  Grand Island, NY) supplemented with 1  (1% 
FCS (Gibco Laboratories). TIB73 cells were seeded at a density of 
105  cells/cm  2 in 35-ram tissue  culture plates  (Falcon  Labware, 
Becton Dickinson & Co., Lincoln Park, NJ) for gentamicin sur- 
vival assay and onto 12-mm diameter glass coverslips in 24-well 
tissue  culture plates  (Falcon  Labware)  for  fluorescence  micros- 
copy. Monolayers were used after 24-48 h of incubation. 
Gentamicin Suwival Assay.  Bacterial  inoculum was  prepared 
as  described for virulence testing.  Cell monolayers grown in 
35-mm tissue culture plates were infected for  1 h  at 37~  at a 
multiplicity of infection of ~100  bacteria  per  cell. After  two 
washings, the cells were reincubated in fresh DMEM containing 
gentamicin (Sigma Chemical Co.) at concentrations of either 5, 
10, or 25 rag/liter. At intervals, they were washed twice and lysed 
by adding cold water. Viable bacteria released from the cells were 
titered on agar plates. 
lmmunofluorescence Microscopy.  Cell monolayers grown on glass 
coverslips were infected as described  above.  At intervals during 
the  incubation period in the  presence  of gentamicin, the  cells 
were washed  twice with PBS,  fixed  with 3% paraformaldehyde 
(wt/vol in PBS) for 30 rain at room temperature, and permeabi- 
lized for 5 rain in 0.1% Triton X-100 (Sigma Chemical Co.)  in 
PBS. Cells were then washed three times with PBS and processed 
for immunolabeling  and actin staining. For immunolabeling, cells 
were incubated sequentially with appropriate  dilutions of a poly- 
clonal rabbit anti-L, monocytogenes EGD antibody and of a FITC 
goat anti-rabbit antibody (Jackson ImmunoP,  esearch Laboratories 
Inc., Bio/Can Scientific,  Mississauga, Canada)  in 1% BSA-PBS; 
incubations were  carried  out for  30  rain at room temperature. 
Rhodamine-phalloidin (Molecular  Probes,  Inc.,  Eugene,  OR) 
was used for F-actin staining_ Coverslips were mounted on slides 
and examined by fluorescence  microscopy using a  microscope 
(Axioskop; Carl Zeiss, Inc., Thornwood, NY). 
Plaque Assay.  Plaque  formation by L.  monocytogenes was as- 
sayed in the mouse L2 fibroblast cell line, using a protocol modi- 
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tained  in  6-weU  tissue  culture  dishes  (Falcon  Labware)  were 
infected with  1-20  p~l of a bacterial  inoculum prepared as de- 
scribed  above. After 1 h  of incubation at 37~  the monolayers 
were washed three times and overlaid  with culture medium con- 
taining 0.75% agarose and 10 p~g of gentamicin per milliliter.  Af- 
ter 3 d, plaques  were visualized  by the addition of 0.1% neutral 
red (Sigma Chemical Co.). 
Results 
Virulence of the inlAB Mutant in Mice.  The  inlAB  mu- 
tant BUG8 and its  parent EGD-SmR were first studied in 
mice infected by the oral route.  Mice were challenged by 
intragastric inoculation of 109 bacteria,  and bacterial spread- 
ing to the liver and spleen was followed as indicative of in- 
testinal  translocation  (Fig.  1).  Both  strains  were  isolated 
from  these  organs  from  day  2,  thus  indicating  that  the 
inlAB  mutant  retained  the  ability  to  invade  the  host 
through  the  gut.  The  bacterial  growth  curves,  however, 
were similar for the two strains in the spleen and dissimilar 
in the liver. The bacterial counts in the spleen were slightly 
lower for BUG8 than for EGD-SmR at all time points, but 
the  growth  curves were parallel.  This  was  not the  case in 
the  liver:  There  was  a  10-fold  difference  in  the  bacterial 
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Figure 1.  Growth curves for EGD-SmR and BUG8 in liver and spleen 
of mice after  oral  and intravenous challenges.  Mice were infected by in- 
tragastric inoculation of 10  9 bacteria  (oral challenge)  or by intravenous in- 
jection  of either 5  ￿  10  s or 2  ￿  10  6 bacteria  (intravenous challenges). 
Bacterial  growth was followed in liver  and spleen by killing  groups of 
mice at intervals.  Data points and error bars represent the mean and SD of 
the logl{  }  bacteria  per organ (mean of five mice for each point). 
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counts of the two strains as early as day 2. BUG8 failed to 
grow and  was  totally  eliminated  from the  liver by day 4, 
whereas  EGD-SmR  proliferated.  Oral  LDs0  experiments 
were  not  performed  because  mice  infected  orally  with 
EGD-SmR  survive  challenges  as  high  as  10  ~~  bacteria 
(Galliard, J.-L., unpublished data). 
Thus,  BUG8 appeared  to be cleared more readily from 
liver  than  EGD-SmR.  This  was  confirmed  by  infecting 
mice by the  intravenous route.  Mice were  challenged in- 
travenously with 5  ￿  10  s or 3  ￿  10  6 bacteria, and bacterial 
growth was followed in liver and spleen  (Fig.  1). With the 
dose of 3  ￿  10  6 bacteria, the bacterial growth curves in the 
spleen  were  comparable  for  the  two  strains  until  day  3, 
when the  first EGD-SmR-infected  mice began to die.  In 
contrast,  the  growth curves in the  liver were  quite  differ- 
ent.  After a fourfold reduction of the inoculum during the 
first 6 h  of infection, EGD-SmR multiplied  rapidly in the 
liver  during  the  first  2  d  of infection  (90-fold increase  in 
bacterial counts from 6 to 48 h). Mice began to die on day 3. 
Of the  10 mice kept to determine bacterial counts on days 
8 and 10, three had died by day 4 and two more by day 6. 
For BUG8,  after  the initial  decrease in bacterial  counts,  a 
low rate of bacterial growth was observed until day 2  (1.5- 
fold increase  in bacterial  counts from 6  to 48  h).  Bacteria 
were  completely  eliminated  from  the  liver  within  8  d. 
None of the BUG8-infected animals died. 
The dose of 5  X  105 bacteria did not result in the death 
of any mouse infected with EGD-SmR or BUG8. This al- 
lowed us to continue the bacterial growth curves over 8  d 
for both strains.  Again,  it  was found that EGD-SmR  and 
BUG8  behaved  similarly  in  the  spleen  and  dissimilarly  in 
the liver during the first days of infection.  In the latter or- 
gan,  the  number of EGD-SmR bacteria increased 20-fold 
and the number of BUG8 bacteria only 1.6-fold from 6 to 
48 h after the challenge. 
The intravenous LDs0s were determined and were 107.55 
for  BUG8  and  106.7{) for  EGD-SmR.  This  difference  is 
consistent  with  the  mortality  rates  observed  during  the 
analysis of bacterial growth in organs after the highest chal- 
lenge. 
Role of inlAB  for Hepatocyte Invasion In Vivo.  Liver  sec- 
tions  from mice  inoculated  intravenously  with  the  inlAB 
mutant BUG8 or EGD-SmR were examined microscopi- 
cally.  A  high  inoculum  (108  bacteria/mouse)  was  used  to 
facilitate  visualization  of bacteria  by  optical  and  electron 
microscopy.  The  histopathology  of livers  from  mice  in- 
fected by EGD-SmR and BUG8 was different.  The livers 
of mice  inoculated  with  EGD-SmR  were  studded  with 
large infectious foci as early as 24 h (Fig. 2, a and c). Consis- 
tent with  recent studies  of other invasive  L.  monocytogenes 
strains  (13,  24),  the  foci  were  constituted  of clusters  of 
heavily infected  hepatocytes and  of inflammatory cells  re- 
cruited locally, predominantly neutrophils (Fig. 3 a). Electron 
microscopy visualized bacteria free within the cytoplasm of 
hepatocytes,  sometimes  dividing,  whereas  in  neutrophils 
the bacteria were confined in all  cases within  phagosomes 
and were often being destroyed (Fig. 3 b). After 48 h  of in- 
fection,  nearly  all  mice inoculated with  EGD-SmR  were Figure 2.  Histological analysis  of mouse liver 24 h after infection with EGD-SmR and BUG8. Mice were challenged intravenously at a dose of 10  s 
bacteria, and liver samples  were obtained 24 h later for microscopic examination. (a and b) Immunoperoxidase labeling using an anti-L, monocytqgenes  se- 
rum as a primary antibody. (a) EGD-SmR: Very large foci of infection are seen. (b) BUG8: The loci of infection are less numerous and much smaller. (c 
and d) Gram staining. (c) EGD-SmR: Many bacteria can be seen, mainly at the periphery of the lesion; note the major inflammatory reaction. (d) BUG8: 
A small number of  bacteria are seen; the inflammatory reaction is barely visible. Bars: (a and b) 25 Ixm; (c and d) 5 txm. 
dead. Very large infectious loci were found in liver sections 
of surviving animals  (Fig.  4  a).  The  centers  of the  lesions 
were necrotic. Bacteria were abundant in peripheral hepa- 
tocytes,  suggesting that  they had  multiplied unrestrictedly 
while propagating radially from hepatocyte to  hepatocyte. 
No animal survived after 72 h  of infection. 
The livers of mice infected with the same dose of BUG8 
gave  a  very  different aspect.  By  24  h,  the  infectious  loci 
were  scarce  and  much  smaller than  those  for  EGD-SmR 
(Fig. 2,  b and  d).  A  typical lesion was populated by a  few 
inflammatory cells and contained no more than  15-25 bac- 
teria. The infectious loci were analyzed by electron micros- 
copy.  They  were  small and  rare,  and  thus  their detection 
required many  more  grids  than  for EGD-SmR.  The  foci 
contained a few inflammatory cells, which had moved out 
of the  sinusoids  and  had  accumulated  locally  (Fig.  3  c). 
Neutrophils  and  mononuclear  cells were  present  in  equal 
proportion, in close physical contact with hepatocytes. Most 
bacteria were  seen  in  inflammatory  cells.  In mononuclear 
cells but not in neutrophils, some appeared free within  the 
cytoplasm and surrounded  by a  dense  microfibrillar mate- 
rial,  presumably actin.  Thus,  some  of the  bacteria  within 
mononuclear  cells  appeared  to  be  capable  of intracellular 
movements  in  the  in  vivo  setting.  A  few  bacteria  were 
found inside hepatocytes adjacent to infected mononuclear 
cells, suggesting that the  hepatocytes might have been in- 
fected through  bacterial spreading from  mononuclear  cell 
to  hepatocyte.  The  rare  bacteria inside  hepatocytes  repli- 
cated freely within the cytoplasm, sometimes appearing as a 
dividing organism coated with  actin.  Some  ultrathin liver 
sections  from  BUG8-infected  mice  displayed  a  different 
pattern (Fig. 3  d): Rare bacteria were confined in a Ktipffer 
cell, without  any  adjacent  inflammatory  cell;  the  bacteria 
were located within vacuoles, and most appeared to be in 
the process of destruction. 
All mice were alive after 48  h  of infection with BUG8. 
The infectious foci in liver had increased in size by local re- 
cruitment of inflammatory cells but remained much smaller 
than  those  observed with  EGD-SmR  after the  same  time 
period (Fig. 4  b).  Bacteria were  detected inside inflamma- 
tory  cells  and  hepatocytes.  Infection  of hepatocytes  re- 
mained  restricted to  a  very few  individual cells, and  each 
362  inlAB-mediated Invasion of Hepatocytes by Listeria monocytogenes Figure 3.  Sernithin  and ultrathin sections of the infectious  loci at 24 h. Semithin (a) and ultrathin (b-d) liver sections  were obtained from mice infected 
as described in the legend to Fig. 2 and examined by light microscopy after staining  with toluidine blue and by electron microscopy, respectively. (a) 
EGD-SmK: The infectious  loci are constituted  of hepatocytes filled with closely  packed Listeria and of inflammatory  cells. (b) EGD-SmR.:  A neutrophil 
(N) can be seen in close physical  proximity  to a heavily  infected  hepatocyte (H); note that bacteria in the hepatocyte are free within the cytoplasm  and ap- 
pear as intact organisms,  whereas those in the neutrophil are confined to vacuoles and in the process of being killed (arrowhead). (c) BUG8: A typical in- 
fectious focus containing  a small  number of inflammatory  cells; the few visible  bacteria are seen within inflammatory  cells rather than within hepatocytes; 
note than some bacteria located within mononuclear cells (M) and hepatocytes (/4) are coated with a dense microfibrillar  material, presumably  actin (ar- 
rowheads). (d) BUG8: A less common picture, in which bacteria  are being destroyed in a Kiipffer  cell (K); note that no inflammatory  cell is seen in the vi- 
cinity of the Kfipffer cell and that adjacent  hepatocytes (H) do not contain any bacterium. Bars: (a) 5 p,m, (b) 1 [a,m; (c and d) 2.5 b~m. 
hepatocyte  contained a  small number of bacteria.  Only a 
small proportion of BUG8-inoculated mice died between 
day 3 and day 7, confirming the weak virulence of BUG8. 
Microscopic examination of liver sections from the surviv- 
ing mice showed a rapid disappearance of bacteria, with a 
complete healing of loci by day 7 (not shown). 
Role of inlAB in Bacterial Entry into Hepatocytic  Cells In  Vi- 
tro.  The histological data suggested that inlAB promotes 
the early entry of L. monocytogenes into hepatocytes and that 
this is a prerequisite for bacterial growth and dissemination 
in the hepatic parenchyma. To investigate the role of inlAB 
for  the  invasion of murine hepatocytes,  we  infected  the 
murine hepatocyte  cell line TIB73  with EGD-SmR  and 
BUG8, complemented or not in trans with inlA  or inlAB. 
Bacterial entry was assessed  using a gentamicin survival as- 
say with an antibiotic concentration of 5  mg/liter.  It was 
found that BUG8 was  ,'-~20-fold less  invasive than EGD- 
SmR (Table 1).  We checked that presumably intracellular 
BUG8 bacteria were  not invasive revertants. 20  indepen- 
dent colonies were randomly selected and assayed for entry. 
In each case, the bacteria exhibited the same phenotype as 
BUG8. The introduction of a plasmid carrying inlAB into 
BUG8 restored completely the ability of this mutant to in- 
vade TIB73 cells, whereas  the  introduction of the vector 
without insert or carrying inlA had no effect on entry (Ta- 
ble  1).  Overall, the levels found with EGD-SmR, BUG8, 
and its derivatives in the TIB73 model were very low com- 
pared with  other  cell systems  (e.g.,  the  Caco-2  cell line) 
(7). However, the numbers of bacteria recovered after gen- 
tamicin treatment with these strains were much higher than 
those found with the k  innocua  strains (Table 1)  and thus 
could not be regarded as background levels due to the pres- 
ence of surviving extracellular bacteria. This was consistent 
with BUG8, suggesting that this mutant was only partially 
entry defective (see below). Also, in contrast with previous 
findings in the Caco-2 model (7), neither the expression of 
inlAB nor that of inlA  was sufficient to promote the entry 
of L.  innocua in TIB73 cells. 
Infection  of TIB73  monolayers  with  EGD-SmR  and 
BUG8 was followed for 18 h in the presence ofgentamicin 
363  Gaillard et al. Figure 4.  Semithin  sections of the 
infectious foci at 48 h. Liver semithin 
sections were obtained after 48  h of 
infection from mice inoculated as de- 
scribed in the legend to Fig. 2 and ex- 
attuned  by light microscopy after tolui- 
dine blue staining. (a) EGD-SmR: A 
typical lesion is shown, consisting  of a 
large area of necrosis surrounded by a 
ring of heavily infected hepatocytes. 
(b) BUG8: The lesion is much smaller; 
inflammatory cells and  bacteria are 
small in number; only a few bacteria 
can be seen within hepatocytes. Bars: 
2.5 b~m. 
at  different  concentrations.  At  given  times,  cells  were 
washed and either lysed for enumerating viable bacteria or 
processed for fluorescence microscopy. Similar results were 
observed  for  the  different  concentrations  of  gentamicin 
tested  (Fig.  5).  BUG8  entered  the  cells with  a  low  effi- 
ciency, but its intracellular growth rate was comparable to 
that  of EGD-SmR  (generation time  of ~-'1  h  during the 
first 8  h  of infection for both strains). Microscopic exami- 
nation of monolayers after irmnunolabeling  of bacteria and 
F-actin staining showed  that BUG8 behaved like the  pa- 
rental strain inside cells.  After 18 h  of infection, the foci of 
bacterial replication formed by both strains were identical 
(Fig.  6);  however,  they  were  10-20-fold  less  numerous 
with BUG8, because of the lower invasive capacity of this 
strain compared with its  parent.  The  ability of BUG8  to 
grow intracellularly and to propagate from cell to cell was 
also evaluated in a plaque assay using the mouse L2 fibro- 
blast cell line (28). Consistent with the data obtained in the 
TIB73 model, plaques formed by BUG8 were  10-20-fold 
less  numerous  than  those  formed  with  EGD-SmR,  but 
their morphology was strictly normal (not shown). 
Discussion 
The aim of this work was to characterize the role of the 
inlAB locus in infection of a living host by L. monocytogenes. 
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Strains  Number of bacteria 
L. monocytogenes 
EGD-SmR  8 (+ 2) ￿  103 
BUG8  4 (+ 3) ￿  102 
JLG101  3 (+ 4) x  102 
JLG102  4 (+ 4.5)  ￿  102 
JLG103  6 (+ 3) x  103 
L. innocua 
CLIP11254  <10 
BUG263  <10 
BUG261  <10 
BUG531  <10 
TIB73 monolayers were infected for 1 h at 37~  with 100 bacteria per 
cell. After washing, the cells were overlaid with f~esh culture medium 
containing gentamicin (5 rag/liter)  and reincubated for 2 h at 37~ 
The cells were then washed again and lysed, and viable bacteria were 
titered on agar plates. The results are expressed as the mean number (+ 
SD) of viable bacteria per well (three determinations). 
This was  addressed by studying the virulence of an inlAB 
mutant and of its parent in murine listeriosis.  Human liste- 
riosis usually occurs by the intestinal  route,  after ingestion 
of Listeria-contaminated  food  products  (29).  InlAB  was 
found to be required for the penetration ofk  monocytogenes 
into  an  enterocytic  cell  line  (7),  and we  therefore  postu- 
lated that this locus was necessary for L. monocytogenes trans- 
location through the gut mucosa. 
Analysis of oral infections in mice showed that the inlAB 
mutant  remained  able  to  cause  a  systemic  infection  after 
oral  challenge,  with  bacterial  spread  to  hver  and  spleen. 
4 
i  ;  ;  ,'8 
HOURS IN PRESENCE OF GENTAMICIN 
Figure  5.  Growth of EGD-SmR  and BUG8 in TIB73 cells. TIB73 
monolayers were infected for 1 h at 37~  with 100 bacteria per cell. After 
washing, the cells were reincubated for 18 h in fresh culture medium con- 
taining gentamicin at a concentration of 5 (￿9  10 ([2), and 25 (A) mg/ 
liter. At intervals, the cells were washed again and lysed, and viable bacte- 
ria were titered on agar plates. Data points and error bars represent the 
mean and SD of the number of bacteria per well (mean of three determi- 
nations). BUG8 was "~20-fold less invasive than EGD-SmP, but multi- 
plied intracellularly to the same extent as its parent. 
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This is in agreement with results of previous experimental 
studies  showing that Listeria given orally to rodents pene- 
trate into the Peyer's patches and not into the intestinal villi 
(23).  As  reported  for  other  bacterial  pathogens  (30-33), 
L. monocytogenes might  thus  use  the  M  cells  within  the 
Peyer's  patches  as  entry  portals.  This  is  consistent  with 
analyses  of the  invasion  of cultured  enterocytic  cells  by 
L. monocytogenes. Indeed, confluent Caco-2 cell monolayers 
are  not permissive  for L.  monocytogenes (11),  and,  in non- 
confluent monolayers, the bacteria enter via cells at the pe- 
riphery of Caco-2 islets  (17). This suggests that L. monocyto- 
genes enters  enterocytic cells by the  basolateral  domain  of 
the  cell  surface,  as  demonstrated  for  Shigella (34).  Thus, 
L. monocytogenes may be  unable  to  invade  enterocytes  by 
their apical pole in the intestine  and require  M  cell trans- 
port for translocating from the intestinal lumen. 
Although our results demonstrate that inlAB is not essen- 
tial to L. monocytogenes for crossing the gut mucosa, they do 
not exclude a role for this locus at the intestinal step of in- 
fection.  It has been suggested that  ShigeUa infection of M 
cells is followed by basolateral infection ofenterocytes (34). 
A  similar process could occur during Listeria infection, in- 
volving  in/AB-dependent  mechanisms.  Enterocytes  may 
thus be the first site of bacterial rephcation in the host. This 
view is supported by a previous electron microscopic study 
in which Listeria given orally to guinea pigs could be seen 
dividing inside enterocytes of the small intestine within 3 h 
of inoculation (35). Furthermore,  our results show that the 
initial counts in hver and spleen  of orally challenged mice 
were substantially lower for the inlAB mutant than for its 
parent. 
Our data provide evidence that the invasion of hepato- 
cytes by L. monocytogenes in mice is promoted by the inlAB 
locus.  First,  the inlAB mutant inoculated into mice by the 
oral and the intravenous routes was severely attenuated for 
growth in the hver. Bacterial counts increased  1.5-fold for 
the inlAB mutant and 90-fold for the parental strain from 6 
to 48 h  after an intravenous challenge of 2  ￿  106 bacteria 
(inlAB mutant 0.1 LDs0  ). Second, histological examination 
of the hvers showed that the inlAB mutant failed to accu- 
mulate in hepatocytes.  24 h  after an intravenous challenge 
of 108 inlAB mutant bacteria, the infectious foci were com- 
posed of a  small  number  of inflammatory cells,  with  few 
visible bacteria;  bacteria were rarely found within hepato- 
cytes by electron microscopy. In contrast, after 24 h  of in- 
fection,  the  foci in the livers  of mice challenged with the 
parental strain consisted of islets  of heavily infected hepato- 
cytes that were infiltrated by numerous inflammatory cells, 
predominantly neutrophils. 
The role of inlAB for the invasion of hepatocytes in vivo 
was strengthened by the results of in vitro experiments us- 
ing the murine hepatocyte cell line TIB73. The inlAB mu- 
tant was ,'-,20-fold less invasive for TIB73 cells than the pa- 
rental  strain  and  recovered  its  invasive  capabihty  when 
inlAB was provided in trans.  In contrast to the results  of a 
previous study using the colon carcinoma cell line Caco-2 
(7), we found that the presence of inlA in trans was not suf- 
ficient to restore the invasive capability of the inlAB mutant Figure 6.  Microscopic examina- 
tion ofTIB73 monolayers 18 h af- 
ter infection with EGD-SmlL and 
BUG8.  TIB73  monolayers were 
infected for  18  h  as described in 
the  legend  to  Fig. 5.  The  cells 
were  then  washed, fixed, perme- 
abilized, and processed for immu- 
nolabeling of bacteria using anti- 
L. monocytogenes  antibody. Plaques 
of infection observed with  EGD- 
Star (a) and BUG8 (b) shared the 
same features. Bars: 5 I-~m. 
for  TIB73  cells.  This  is  in  full  agreement  with  a  recent 
study from Dramsi et al., in which different cell lines were 
infected with  inIA,  inlB,  and inlAB deletion mutants  from 
strain  EGD  (36).  These  authors  have  shown  that  inlB  is 
necessary to  the entry of L.  monocytogenes into the cell line 
TIB73  and,  to  a  lesser extent,  into  the  human  hepatoma 
cell line HepG2.  Thus,  the  entry of L.  monocytogenes  into 
hepatocytes appears to require the coordinate expression of 
inlA  and  inlB.  Moreover,  since the  expression of inlAB is 
not sufficient to promote  the entry of L.  innocua into  cul- 
tured  hepatocytes  (36;  this  study),  other L.  monocytogenes- 
specific  genes,  possibly belonging to  the  inl  gene  family, 
may also be necessary for the completion of this process. 
Some in vitro results may explain the behavior of  the inlAB 
mutant in the liver of mice.  First, this strain was only par- 
tially entry defective, presumably because L.  rnonocytogenes 
possesses  other  invasion  determinants  than  inlAB.  This 
might account, at least partially (see below), for the low de- 
gree  of hepatocyte  invasion  observed  in  mice  inoculated 
with  the  inlAB  mutant.  Another  interesting result  arising 
from in vitro studies was the  demonstration that,  once in- 
side host cells, the inIAB mutant behaves in the same man- 
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taining  hundreds  of intracellular  bacteria  were  observed 
with  both  strains  in  TIB73  monolayers.  Moreover,  the 
inlAB  mutant formed normal plaques in  mouse L2 fibro- 
blast  monolayers,  confirming  that  this  strain  retained  its 
ability to spread from cell to cell. 
Together, these data suggest the existence of two distinct 
pathways  of hepatocyte invasion by L.  monocytogenes (Fig. 
7).  The first steps  of infection are common to both path- 
ways.  The  bacteria  circulating  in  the  liver sinusoids  are 
trapped by Kfipffer cells, where most of them are destroyed 
rapidly.  A  variable proportion  of bacteria,  depending  on 
the  inoculum  size,  is  able  to  escape  from the  phagolyso- 
somes of K/.ipffer cells and replicate. In the first pathway of 
hepatocyte invasion  (Fig.  7  a),  the  bacteria  might  be  re- 
leased from damaged Kfipffer cells into the extracellular en- 
vironment and enter hepatocytes by a phagocytic-like pro- 
cess  induced  by  InlAB.  It  is  likely  that  this  pathway  is 
greatly favored by heavy bacterial burdens as it requires the 
destruction of Kfipffer cells  (compare the bacterial growth 
curves in  the livers of mice challenged with 5  ￿  10  ~  and 
3  ￿  106 EGD-SmR bacteria in Fig.  1). 
Data from some electron micrographs suggest that a sec- 
ond pathway may occur involving the actin-based propaga- 
tion of the bacteria from Kiipffer cells  (or, at later stages, 
from monocytes recruited locally) to adjacent hepatocytes 
(Fig.  7  b). This pathway is probably much less sensitive to 
the  inoculum size  and  may play a  major role at  the low 
doses  occurring  in  natural  infections.  The  expression  of 
actA is essential  to the completion of this process but also to 
the  propagation  of L.  monocytogenes from  hepatocyte  to 
hepatocyte. Thus, an actA mutant can enter hepatocytes via 
the first pathway but cannot disseminate in the liver paren- 
chyma. This explains how an actA mutant (37) is much less 
virulent than  an  inlAB  mutant,  which  enters hepatocytes 
a  b 
C  C 
//J 
Figure 7.  Models  ofhepatocyte  invasion  by L. monocytogenes. (a) inlAB- 
mediated invasion by bacteria released from damaged Kfipffer  cells. (b) 
Actin-based passage from Kfipffer  cells to hepatocytes. 
via the second pathway and subsequently is able to spread 
from hepatocyte to hepatocyte. Although the inlAB mutant 
behaves normally in terms of cell-to-cell spreading, it gives 
infectious loci of small size in the livers of mice compared 
with its parental strain.  The most likely explanation is that 
this mutant enters hepatocytes less eflficiently as it uses only 
the second pathway and is therefore controlled more easily 
by the host's immune system. 
To establish  inside a mammalian host, an invasive patho- 
gen must resist the host's innate defense mechanisms. The 
most common and direct way is to synthesize surface mole- 
cules with antiphagocytic activity, for example, polymers of 
repeated  sugar  residues  (e.g.,  polysaccharide  capsules)  or 
various proteins  (8).  An indirect and more subtle way is 
to invade cells that are not armed to destroy bacteria, such 
as  epithelial  or  parenchymal  cells  (8).  These  nonprofes- 
sional phagocytic cells constitute a sanctuary where bacteria 
can  multiply  until  a  specific immune  response  develops. 
L.  monocytogenes appears to have evolved the latter strategy. 
Using L.  monocytogenes as a model, we report the first ev- 
idence that the expression of invasion loci allows a patho- 
gen to evade the host's innate defense mechanisms by tak- 
ing shelter in  nonprofessional phagocytes.  The  timing  of 
this evasion is important.  In murine listeriosis,  the hepato- 
cytes are  invaded  early in  the  course of infection, before 
neutrophils populate the sites of  bacterial implantation (24). 
The bacteria can then multiply and propagate in the host 
tissues by cell-to-cell spreading, preceding phagocytes that 
are  recruited  locally.  Infection  of liver  parenchyma  by 
L.  monocytogenes can thus be seen as a race between the mi- 
croorganism and the immune  cells.  L.  monocytogenes must 
enter the hepatocytes and multiply to numbers capable of 
overwhelming the host's immune response.  Kfipffer cells, 
neutrophils, and monocytes must hold infection to a level 
that can be resolved subsequently by a T  cell-mediated re- 
sponse. 
L.  monocytogenes is  commonly regarded  as  a  facultative 
intracellular pathogen  whose  trademark  is  to  survive  and 
replicate inside host macrophages (9, 38). The resolution of 
L.  monocHogenes infection is therefore believed to  depend 
on a T  cell-mediated activation ofmacrophages, enhancing 
their microbicidal  activity  (38-40).  This  study  and  other 
reports  (13,  24-26)  demonstrate that  the principal  site  of 
replication ofL. monocytogenes in a living host is the hepato- 
cyte and not the macrophage. By analogy, this may also be 
true for other facultative intracellular pathogens. It has been 
shown  recently that  Salmonella  typhimurium  and  Francisella 
tularensis also  multiply extensively in  hepatocytes in  mice 
(41). An intriguing question is whether the immune system 
interacts with infected nonphagocytic cells  as it does with 
professional phagocytes to control the bacterial multiplica- 
tion.  Some  relevant  data  have  been  reported.  Listeria- 
infected mouse hepatocytes are selectively lysed by neutro- 
phils, which are recruited in the infectious foci (13,  24). It 
has also been suggested that hepatocytes could be induced 
to kill Listeria by IFN-~/(42). This fascinating aspect of bac- 
terial immunity is just starting to be explored. 
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